Doronina, Svetlana O <br/><br/>
Development of potent monoclonal antibody auristatin conjugates for cancer therapy.  [electronic resource] 

 -  Nature biotechnology  Jul 2003 
 - 778-84 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1087-0156 
<br/><br/><label>Standard No.: </label>10.1038/nbt832  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Cells, Cultured--drug effects<br/>Drug Delivery Systems--methods<br/>Drug Stability<br/>Humans<br/>Immunotoxins--adverse effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mice, SCID<br/>Neoplasm Transplantation<br/>Oligopeptides--adverse effects<br/>Protein Binding<br/>Treatment Outcome